32nd week of 2017 patent applcation highlights part 9 |
Patent application number | Title | Published |
20170224689 | NOVEL PYRROLOPYRIMIDINE COMPOUNDS AS INHIBITORS OF PROTEIN KINASES | 2017-08-10 |
20170224690 | SMALL MOLECULE TRAIL GENE INDUCTION BY NORMAL AND TUMOR CELLS AS AN ANTICANCER THERAPY AND TUMOR CELLS AS AN ANTICANCER THERAPY | 2017-08-10 |
20170224691 | PDE INHIBITORS IN IMMUNOTHERAPY | 2017-08-10 |
20170224692 | Combination Therapy | 2017-08-10 |
20170224693 | INDUCTION OF TUMOR HYPOXIA FOR CANCER THERAPY | 2017-08-10 |
20170224694 | POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITY | 2017-08-10 |
20170224695 | POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITY | 2017-08-10 |
20170224696 | TRIAZINE COMPOUNDS AS PI3 KINASE AND MTOR INHIBITORS | 2017-08-10 |
20170224697 | 3-(1H-IMIDAZO[4,5-C]PYRIDIN-2-YL)-1H-PYRAZOLO[3,4-B]PYRIDINE AND THERAPEUTIC USES THEREOF | 2017-08-10 |
20170224698 | USE OF PARTHENOLIDE DERIVATIVES AS ANTILEUKEMIC AND CYTOTOXIC AGENTS | 2017-08-10 |
20170224699 | NOVEL IMMUNE SYSTEM MODULATORS | 2017-08-10 |
20170224700 | USES OF SALT-INDUCIBLE KINASE (SIK) INHIBITORS | 2017-08-10 |
20170224701 | INHIBITORS OF TRYPTOPHAN DIOXYGENASES (IDO1 and TDO) AND THEIR USE IN THERAPY | 2017-08-10 |
20170224702 | COMBINATION ALZHEIMER THERAPY USING ANTI-N3PGLU ABETA ANTIBODIES + A BACE INHIBITOR | 2017-08-10 |
20170224703 | ANTIFUNGAL AGENTS AND USES THEREOF | 2017-08-10 |
20170224704 | TROPOMYOSIN-RELATED KINASE (TRK) INHIBITORS | 2017-08-10 |
20170224705 | BICYCLIC HETEROCYCLE COMPOUNDS AND THEIR USES IN THERAPY | 2017-08-10 |
20170224706 | AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS AND USES THEREOF | 2017-08-10 |
20170224707 | CHOLESTEROL LOWERING CAPSULES | 2017-08-10 |
20170224708 | MODIFIED HYALURONIC ACID POLYMER COMPOSITIONS AND RELATED METHODS | 2017-08-10 |
20170224709 | METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE USING PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) INHIBITORS | 2017-08-10 |
20170224710 | COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING COMPLEX REGIONAL PAIN SYNDROME | 2017-08-10 |
20170224711 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | 2017-08-10 |
20170224712 | PROCHELATORS AS BROAD-SPECTRUM ANTIMICROBIAL AGENTS AND METHODS OF USE | 2017-08-10 |
20170224713 | HETEROCYCLIC COMPOUNDS FOR TREATING OR PREVENTING DISORERS CAUSED BY REDUCED NEUROTRANSMISSION OF SEROTONIN, NOREPHNEPHRINE OR DOPAMINE | 2017-08-10 |
20170224714 | METHODS FOR DECREASING THE INCIDENCE OF NECROTIZING ENTEROCOLITIS IN INFANTS, TODDLERS, OR CHILDREN USING HUMAN MILK OLIGOSACCHARIDES | 2017-08-10 |
20170224715 | REMOTE LOADING OF SPARINGLY WATER-SOLUBLE DRUGS INTO LIPID VESICLES | 2017-08-10 |
20170224716 | Methods and Compositions for Treating Pain | 2017-08-10 |
20170224717 | RENAL INSUFFICIENCY PROGRESSION INHIBITOR, PROPHYLACTIC AGENT FOR RENAL INSUFFICIENCY AND INDOXYL SULFATE PRODUCTION INHIBITOR | 2017-08-10 |
20170224718 | METHOD OF TREATING AND PREVENTING NEURO-OLFACTORY TRIGGERED OR AGGRAVATED ILLNESSES OR RELATED CONDITIONS | 2017-08-10 |
20170224719 | CHOLESTYRAMINE PELLETS AND METHODS FOR PREPARATION THEREOF | 2017-08-10 |
20170224720 | ORAL CHOLESTYRAMINE FORMULATION AND USE THEREOF | 2017-08-10 |
20170224721 | ORAL CHOLESTYRAMINE FORMULATION AND USE THEREOF | 2017-08-10 |
20170224722 | COMPOSITION AND METHOD FOR PRE-SURGICAL SKIN DISINFECTION | 2017-08-10 |
20170224723 | METHOD FOR PRODUCING POLYGUANIDINES | 2017-08-10 |
20170224724 | IONIC COCRYSTAL OF LITHIUM, LISPRO, FOR THE TREATMENT OF FRAGILE X SYNDROME | 2017-08-10 |
20170224725 | USE OF NITRITE SALTS IN TREATING TISSUE DAMAGE | 2017-08-10 |
20170224726 | COMPOSITIONS AND METHODS FOR PAIN RELIEF WITHOUT NUMBNESS | 2017-08-10 |
20170224727 | METHOD FOR REGULATION OF LIPID METABOLISM | 2017-08-10 |
20170224728 | IRON-BASED MONTMORILLONITE MEDICAMENT FOR TREATING HYPERPHOSPHATEMIA AND IRON-DEFICIENCY ANEMIA, AND PREPARATION METHOD THEREFOR | 2017-08-10 |
20170224729 | COMPOSITION COMPRISING CINNAMALDEHYDE AND ZINC TO IMPROVE SWALLOWING | 2017-08-10 |
20170224730 | ANTI-CANCER EFFECTS OF PROTEASOME INHIBITORS IN COMBINATION WITH GLUCOCORTICOIDS, ARSENIC CONTAINING COMPOUNDS, AND ASCORBIC ACID | 2017-08-10 |
20170224731 | METHOD OF PRODUCING LEUKOCYTES USING PTPN2 INHIBITION FOR ADOPTIVE CELL TRANSFER | 2017-08-10 |
20170224732 | DISCOVERY OF REGULATORY T CELLS PROGRAMMED TO SUPPRESS AN IMMUNE RESPONSE | 2017-08-10 |
20170224733 | Administration of Engineered T Cells for Treatment of Cancers in the Central Nervous System | 2017-08-10 |
20170224734 | Tumor Infiltrating Cells Engineered to Express a Pro-Inflammatory Polypeptide | 2017-08-10 |
20170224735 | COMPOSITIONS, METHODS, AND COMPUTER SYSTEMS RELATED TO MAKING AND ADMINISTERING MODIFIED T CELLS | 2017-08-10 |
20170224736 | METHOD AND APPARATUS FOR RECOVERY OF UMBILICAL CORD TISSUE DERIVED REGENERATIVE CELLS AND USES THEREOF | 2017-08-10 |
20170224737 | ENGRAFTMENT OF STEM CELLS WITH A COMBINATION OF AN AGENT THAT TARGETS STEM CELLS AND MODULATION OF IMMUNOREGULATORY SIGNALING | 2017-08-10 |
20170224738 | A METHOD FOR PROTECTING LIVER AND A LIVER PROTECTING AGENT | 2017-08-10 |
20170224739 | PLACENTAL STEM CELLS DERIVED FROM POST-PARTUM MAMMALIAN PLACENTA, AND USES AND METHODS OF TREATMENT USING SAID CELLS | 2017-08-10 |
20170224740 | Methods for treating nervous system injury and disease | 2017-08-10 |
20170224741 | MODULATION OF STEM CELLS USING ZINC FINGER PROTEINS | 2017-08-10 |
20170224742 | PHOSPHOLIPID-CONTAINING MARINE EXTRACTS FOR TREATMENT OF CARDIOVASCULAR DISEASES | 2017-08-10 |
20170224743 | METHOD FOR THE TREATMENT OF ACNE | 2017-08-10 |
20170224744 | USES OF BACTEROIDES IN TREATMENT OR PREVENTION OF OBESITY AND OBESITY-RELATED DISEASES | 2017-08-10 |
20170224745 | BACILLUS AMYLOLIQUEFACIENS PROBIOTIC COMPOSITIONS, METHODS OF PRODUCTION, AND METHODS OF USE | 2017-08-10 |
20170224746 | Nutritional Support Method For Health Issues | 2017-08-10 |
20170224747 | MICROORGANISMS INHIBITING THE FORMATION OF AXILLARY MALODOR | 2017-08-10 |
20170224748 | Materials and Methods for Improving Immune Responses and Skin and/or Mucosal Barrier Functions | 2017-08-10 |
20170224749 | VAGINAL COMPOSITION FOR THE TREATMENT OF UROGENITAL INFECTIONS | 2017-08-10 |
20170224750 | LACTOBACILLUS PLANTARUM CNCM I-4026 PREPARATIONS AND SKIN HEALTH | 2017-08-10 |
20170224751 | EXTRACTS OF MICROALGAE AND PLANTS FOR REGULATING SEBUM PRODUCTION | 2017-08-10 |
20170224752 | ANTRODIA CAMPHORATA AND GANODERMA LUCIDUM COMPOSITION HAVING FUNCTIONALITY TO INHIBIT RENAL CANCER CELL GROWTH AND ENHANCE KIDNEY FUNCTIONMPOSITION | 2017-08-10 |
20170224753 | Homogeneous Composition of Plant-Based Oils and Hydrosols | 2017-08-10 |
20170224754 | PHARMACEUTICAL COMPOSITION CONTAINING COMBINATION EXTRACTS OF MOUTAN ROOT BARK, ANGELICA DAHURICA ROOT, BUPLEURUM ROOT OR FRACTIONS THEREOF FOR PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISORDER | 2017-08-10 |
20170224755 | SENSITIZATION COMPOSITION AND METHOD OF USE | 2017-08-10 |
20170224756 | Antioxidants Against Oxidative Stress During a Stressor Event | 2017-08-10 |
20170224757 | NATURAL EXTRACTS FOR MODULATING PP2A METHYLATION, AND PROVIDING ANTIOXIDANT AND ANTI INFLAMMATORY ACTIVITY | 2017-08-10 |
20170224758 | COMPOSITIONS AND METHODS OF TREATING MUSCULAR DYSTROPHY | 2017-08-10 |
20170224759 | COMPOSITIONS AND METHODS FOR TREATING COLORECTAL CANCER | 2017-08-10 |
20170224760 | COMPOSITIONS AND METHODS FOR INVASIVE AND NON-INVASIVE PROCEDURAL SKINCARE | 2017-08-10 |
20170224761 | Methods for Administering Angiotensin II | 2017-08-10 |
20170224762 | Method and Formulation for Inhalation | 2017-08-10 |
20170224763 | OXYTOCIN TREATMENT TO IMPROVE MEMORY AND MODIFY BLOOD GLUCOSE | 2017-08-10 |
20170224764 | THERAPEUTIC TARGETING OF MITOCHONDRIA TO PREVENT OSTEOARTHRITIS | 2017-08-10 |
20170224765 | TREATMENTS OF HEPATITIS C VIRUS INFECTION | 2017-08-10 |
20170224766 | OPHTHALMIC COMPOSITION COMPRISING CYCLOSPORINE AND TREHALOSE | 2017-08-10 |
20170224767 | FORMULATIONS OF VANCOMYCIN | 2017-08-10 |
20170224768 | LEUKOTOXIN E/D AS A NEW ANTI-INFLAMMATORY AGENT AND MICROBICIDE | 2017-08-10 |
20170224769 | PHARMACEUTICAL COMPOSITION FOR SUPPRESSING CELL TRANSPLANT REJECTION | 2017-08-10 |
20170224770 | METHODS FOR PREVENTING OR TREATING DISORDERS BY INCREASING BIOAVAILABILITY OF IRON AND RELATED PHARMACEUTICAL FORMULATION | 2017-08-10 |
20170224771 | HISTATINS AS THERAPEUTIC AGENTS FOR OCULAR SURFACE DISEASE | 2017-08-10 |
20170224772 | COMPOSITION AND KIT FOR PREVENTION OR TREATMENT OF ARTHRITIS, AND METHOD USING THE SAME | 2017-08-10 |
20170224773 | PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING ESOPHAGEAL STENOSIS | 2017-08-10 |
20170224774 | METHOD FOR USING SUPPLEMENTAL VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) OR ANALOG TO PREVENT OXYGEN INDUCED ARREST OF VESSEL GROWTH AND DISEASE SEQUELA OF PREMATURE INFANT BIRTH | 2017-08-10 |
20170224775 | Lv PEPTIDE, ANTI-Lv ANTIBODY AND METHODS THEREOF | 2017-08-10 |
20170224776 | METHODS TO ENHANCE NERVE REGENERATION UTILIZING NEURAL STEM CELLS AND IL12P40 | 2017-08-10 |
20170224777 | SYNERGISTIC TUMOR TREATMENT WITH IL-2, A THERAPEUTIC ANTIBODY, AND A CANCER VACCINE | 2017-08-10 |
20170224778 | COMPOSITIONS AND METHODS THAT TARGET REGULATION OF BREATHING | 2017-08-10 |
20170224779 | METHODS FOR TREATING CARDIOVASCULAR DYSFUNCTION AND IMPROVING FLUID HOMEOSTASIS WITH A PEPTIDE HORMONE | 2017-08-10 |
20170224780 | METHODS FOR PREVENTING TRANSPLANTATION-INDUCED FOLLICLE ACTIVATION | 2017-08-10 |
20170224781 | Y1 receptor activator for treating an anticancer agent-induced nephrotoxic injury | 2017-08-10 |
20170224782 | TREATMENT OF DEPRESSION AND PTSD | 2017-08-10 |
20170224783 | METHODS AND COMPOSITIONS FOR TREATMENT OF MITOCHONDRIAL DISORDERS | 2017-08-10 |
20170224784 | FUNCTIONAL FOODS COMPRISING DIAMINE OXIDASE AND USES THEREOF | 2017-08-10 |
20170224785 | SUBCUTANEOUS ADMINISTRATION OF ADAMTS13 | 2017-08-10 |
20170224786 | BOTULINUM TOXIN COMPOSITIONS | 2017-08-10 |
20170224787 | COMPOSITIONS AND METHODS FOR TREATMENT OF HOMOCYSTINURIA | 2017-08-10 |
20170224788 | C1-INH COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF DISORDERS ASSOCIATED WITH C1 ESTERASE INHIBITOR DEFICIENCY | 2017-08-10 |